82 related articles for article (PubMed ID: 3860300)
41. Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography.
Deesen PE; Leyland-Jones B
Drug Metab Dispos; 1984; 12(1):9-13. PubMed ID: 6141919
[TBL] [Abstract][Full Text] [Related]
42. An increase of serum lipids after cumulative doses of doxorubicin and epirubicin in experimental animals.
Stathopoulos GP; Papadopoulos NG; Stephanopoulou A; Dontas I; Kotsarelis D; Karayannacos PE
Anticancer Res; 1996; 16(6B):3429-33. PubMed ID: 9042202
[TBL] [Abstract][Full Text] [Related]
43. Adriamycin, an antitumour antibiotic: a review with special reference to daunomycin.
Skovsgaard T; Nissen NI
Dan Med Bull; 1975 Feb; 22(2):62-73. PubMed ID: 1093818
[No Abstract] [Full Text] [Related]
44. Chronic myeloid leukemia after living donor liver transplantation.
Concejero A; Chen CL; Wang CC; Wang SH; Lin CC; Liu YW; Yang CH; Yong CC; Wang MC; Eng HL
Transplantation; 2007 Jun; 83(11):1521-2. PubMed ID: 17565329
[No Abstract] [Full Text] [Related]
45. A comparison of toxicity of two dosing schemes for doxorubicin in the cat.
Reiman RA; Mauldin GE; Neal Mauldin G
J Feline Med Surg; 2008 Aug; 10(4):324-31. PubMed ID: 18434224
[TBL] [Abstract][Full Text] [Related]
46. Surgical management after doxorubicin and epirubicin extravasation.
Fleming A; Butler B; Gault D
J Hand Surg Br; 1999 Jun; 24(3):390. PubMed ID: 10433467
[No Abstract] [Full Text] [Related]
47. Comment on mitoxantrone.
DuKart G; Iatropoulos MJ; Yacobi A
Drug Intell Clin Pharm; 1985 Mar; 19(3):216-8. PubMed ID: 3979268
[No Abstract] [Full Text] [Related]
48. Serum troponin T levels in adults undergoing anthracycline therapy.
Raderer M; Kornek G; Weinländer G; Kastner J
J Natl Cancer Inst; 1997 Jan; 89(2):171. PubMed ID: 8998187
[No Abstract] [Full Text] [Related]
49. [Treatment of cancer with cytostatics: results with high dose therapy with cyclophosphamide and drug targeting with doxorubicin].
Busse D; Kroemer HK; Sperker B; Mürdter TE
Pharm Unserer Zeit; 1998 Sep; 27(5):216-22. PubMed ID: 9800467
[No Abstract] [Full Text] [Related]
50. Activity of epirubicin in pancreatic carcinoma.
Hochster H; Green MD; Speyer JL; Wernz JC; Blum RH; Muggia FM
Cancer Treat Rep; 1986 Feb; 70(2):299-300. PubMed ID: 3456273
[No Abstract] [Full Text] [Related]
51. The efficacy of caelyx and hyperthermia for anticancer treatment.
Kouloulias VE; Koukourakis GV; Petridis AK; Kouvaris I; Gouliamos AD
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):246-50. PubMed ID: 18221068
[TBL] [Abstract][Full Text] [Related]
52. Assay of doxorubicin and 4'-epidoxorubicin by reversed-phase ion-pair chromatography.
Thomas AH; Quinlan GJ; Gutteridge JM
J Chromatogr; 1984 Sep; 299(2):489-94. PubMed ID: 6594342
[No Abstract] [Full Text] [Related]
53. Useful new anti-cancer agent.
Practitioner; 1985 Apr; 229(1402):310. PubMed ID: 3857565
[No Abstract] [Full Text] [Related]
54. Assessment of ventricular function by radionuclide angiography in patients receiving 4'-epidoxorubicin and mitoxantrone.
Elisson O
Cancer Chemother Pharmacol; 1986; 17(3):296-7. PubMed ID: 3461888
[No Abstract] [Full Text] [Related]
55. Drugs recently released in Belgium: epirubicin and enalapril maleate.
Harvengt C
Acta Clin Belg; 1985; 40(5):329-32. PubMed ID: 3004077
[No Abstract] [Full Text] [Related]
56. Mortality.
Nishihara T
Nature; 1989 Jul; 340(6230):180. PubMed ID: 2818725
[No Abstract] [Full Text] [Related]
57. [4'-epidoxorubicin].
Mechl Z
Cas Lek Cesk; 1985 Jun; 124(24):755-7. PubMed ID: 3860300
[No Abstract] [Full Text] [Related]
58. American symposium looks at new antineoplastic drug.
Korcok M
Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
[No Abstract] [Full Text] [Related]
59. [Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
Lopez M; Di Lauro L; Papaldo P; Lazzaro B
Clin Ter; 1984 Apr; 109(1):31-5. PubMed ID: 6233078
[No Abstract] [Full Text] [Related]
60. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
